Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Meeting ReportAnnual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), Stockholm, Sweden, June 26–27, 2012

GRAPPA Educational Initiatives: A report from the GRAPPA 2012 Annual Meeting

Philip J. Mease
The Journal of Rheumatology August 2013, 40 (8) 1457-1458; DOI: https://doi.org/10.3899/jrheum.130464
Philip J. Mease
From the Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pmease@philipmease.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Abstract

A key mission of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) is to provide education about psoriasis and psoriatic arthritis (PsA) to clinicians. Among the global educational initiatives in 2012, GRAPPA worked collaboratively with several Latin American medical societies to organize a meeting of rheumatologists and dermatoligists in Buenos Aires; a second meeting is planned for Mexico City in September 2013. GRAPPA members also collaborated with the Spondyloarthritis Research and Therapy Network to conduct a series of continuing medical education symposia throughout the United States to update rheumatologists about new findings in PsA and spondyloarthritis. Finally, GRAPPA faculty presented a teaching module on PsA at an Asian regional conference in Singapore. Summaries of these activities are presented here.

Key Indexing Terms:
  • PSORIASIS
  • PSORIATIC ARTHRITIS
  • SPARTAN

In September 2012, in conjunction with several Latin American organizations (Latin American Psoriasis and Psoriatic Arthritis Society, Society of Latin American Psoriasis, and Pan-American League Against Rheumatism), GRAPPA members hosted 260 dermatologists and rheumatologists in a 2-day symposium on psoriasis and PsA. [Financial support was provided by Abbott.] Meeting organizers were Enrique Soriano and Morton Scheinberg, and GRAPPA presenters included Alberto Berman, Wolf-Henning Boehncke, Luis Espinosa, Dafna Gladman, Philip Helliwell, Philip Mease, Claudia Schainberg, Morton Scheinberg, Enrique Soriano, Sergio Toloza, and Rafael Valle-Onate. In plenary lectures on disease genetics, pathogenesis, epidemiology, clinical presentation, assessment, and treatment, significant emphasis was placed on collaboration between dermatologists and rheumatologists. Meet-the-professor sessions to discuss difficult cases and treatment approaches were included, as were hands-on workshops for physical examination and ultrasound of PsA and spondyloarthritis (SpA) patients. Enthusiasm in this interdisciplinary meeting was palpable, and a second meeting will occur in Mexico City in September 2013.

Another GRAPPA collaboration is a continuing medical educational (CME) project being conducted with the Spondyloarthritis Research and Therapy Network (SPARTAN). As new findings about PsA and SpA have emerged recently, we recognize the need for in-depth education of rheumatologists, rheumatology fellows, nurse practitioners, and physician assistants. Members of SPARTAN and North American members of GRAPPA, the majority of whom belong to both organizations, created a program of plenary lectures and breakout workshops. Table 1 provides a typical agenda of the day-long symposium. To date, 6 well attended symposia have been held in cities around the US. Lectures are updated as new information becomes available from scientific meetings. Some key new educational messages: (1) Genetic data on ankylosing spondylitis (AS) and PsA. (2) US epidemiology data from a recent NHANES survey, which suggests that 0.9%–1.4% of the US population may have axial SpA, compared to 0.5% with AS. (3) Classification criteria for PsA, axial SpA, and peripheral SpA. (4) Discovery of a unique population of resident entheseal T cells in an SpA animal model, which become activated by IL-23 and lead to activation of the TH17 pathway, which in turn can lead to inflammation and both erosive and osteoproliferative effects. (5) Understanding the pathogenic role of HLA-B27. (6) Clinical presentation and assessment of heterogeneous domains of arthritis, enthesitis, dactylitis, spondylitis, and skin and nail disease. (7) Composite disease severity and response measures that can provide thresholds for targeted treatment. (8) Treatment recommendations. (9) Data on emerging therapies. (10) Classification, clinical presentation, and management of pediatric enthesitis-related arthritis (ERA), juvenile PsA, and juvenile AS. (11) Comorbidities of PsA and SpA, with an emphasis on cardiovascular disease that has been particularly associated with PsA and metabolic syndrome. (12) Hands-on evaluation of patients to learn PsA and SpA-specific physical examination and ultrasound technique; includes focused workshop on evaluation of magnetic resonance imaging (MRI) scans.

In addition to full-day symposia, GRAPPA/SPARTAN faculty have developed half-day (4 lectures) and quarter-day (2 lectures) symposia that distill key educational messages and provide CME options for regional events. To date, one each of these half-day and quarter-day events has occurred.

In October 2012, 3 GRAPPA members, Peter Nash, Katy Leung Ying Ying, and James Louie, provided PsA education in the Ten Topics in Rheumatology Asia meeting in Singapore, a recurring annual conference that brings state-of-the-art lectures to Asia at affordable cost. In this conference, disease activity assessment, management updates, and the cardiovascular profile in PsA were discussed among 177 delegates from 9 Asian countries. A preconference workshop in spondyloarthropathies attracted 50 rheumatology trainees, where assessments of psoriasis disease activity in PsA were discussed, and hands-on sessions were included for assessment of skin, joints, and various manifestations of PsA.

Several educational initiatives are planned in 2013. The CME series on PsA and SpA conducted by GRAPPA and SPARTAN will continue in cities throughout the US. Three GRAPPA members, Philip Helliwell, Oliver FitzGerald, and Laura Coates, will lecture on various aspects of PsA in the Fourth Congress of Psoriasis International Network in Paris in early July. In mid-July, the annual meeting of GRAPPA will be held in Toronto, where a day-long educational symposium on PsA will be conducted in conjunction with the 35th year of the Psoriatic Arthritis Research Program led by Dafna Gladman at the University of Toronto.

Additional educational projects were proposed at the GRAPPA annual meeting, including the creation of a CME symposium series on psoriasis and PsA (analogous to the PsA-SpA symposia), targeting a dermatology and rheumatology audience in selected cities globally. Philip Helliwell also proposed creation of educational slides on psoriasis and PsA, to be posted online for teaching purposes (analogous to those on SpA available on the Assessment of Spondyloarthritis international Society website). Amit Garg described the unmet need for training of dermatology residents about psoriasis and PsA. He proposed a curriculum development project for dermatology and rheumatology training programs, which might include GRAPPA members in a visiting faculty program.

View this table:
  • View inline
  • View popup
Table 1.

Suggested one-day SPARTAN-GRAPPA Educational Symposium Agenda* (names of experts who developed each talk are shown in italics).

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 40, Issue 8
1 Aug 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
GRAPPA Educational Initiatives: A report from the GRAPPA 2012 Annual Meeting
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
GRAPPA Educational Initiatives: A report from the GRAPPA 2012 Annual Meeting
Philip J. Mease
The Journal of Rheumatology Aug 2013, 40 (8) 1457-1458; DOI: 10.3899/jrheum.130464

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
GRAPPA Educational Initiatives: A report from the GRAPPA 2012 Annual Meeting
Philip J. Mease
The Journal of Rheumatology Aug 2013, 40 (8) 1457-1458; DOI: 10.3899/jrheum.130464
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
  • eLetters

Keywords

PSORIASIS
PSORIATIC ARTHRITIS
SPARTAN

Related Articles

Cited By...

More in this TOC Section

  • Ultrasound Imaging Module: Report from the GRAPPA 2012 Annual Meeting
  • Biomarkers: Project Update from the GRAPPA 2012 Annual Meeting
Show more Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), Stockholm, Sweden, June 26–27, 2012

Similar Articles

Keywords

  • psoriasis
  • psoriatic arthritis
  • SPARTAN

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire